- Home
- XPER vs BNTC Comparison
XPER vs BNTC Comparison
Compare XPER & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPER
- BNTC
- Stock Information
- Founded
- XPER 1990
- BNTC 1995
- Country
- XPER United States
- BNTC United States
- Employees
- XPER N/A
- BNTC N/A
- Industry
- XPER Semiconductors
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- XPER Technology
- BNTC Health Care
- Exchange
- XPER Nasdaq
- BNTC Nasdaq
- Market Cap
- XPER 304.4M
- BNTC 365.1M
- IPO Year
- XPER 2003
- BNTC N/A
- Fundamental
- Price
- XPER $5.44
- BNTC $12.99
- Analyst Decision
- XPER Strong Buy
- BNTC Strong Buy
- Analyst Count
- XPER 2
- BNTC 5
- Target Price
- XPER $11.00
- BNTC $26.60
- AVG Volume (30 Days)
- XPER 486.2K
- BNTC 311.6K
- Earning Date
- XPER 11-05-2025
- BNTC 11-14-2025
- Dividend Yield
- XPER N/A
- BNTC N/A
- EPS Growth
- XPER N/A
- BNTC N/A
- EPS
- XPER 0.15
- BNTC N/A
- Revenue
- XPER $453,960,000.00
- BNTC N/A
- Revenue This Year
- XPER N/A
- BNTC N/A
- Revenue Next Year
- XPER $6.47
- BNTC N/A
- P/E Ratio
- XPER $35.47
- BNTC N/A
- Revenue Growth
- XPER N/A
- BNTC N/A
- 52 Week Low
- XPER $5.40
- BNTC $9.10
- 52 Week High
- XPER $11.08
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- XPER 26.67
- BNTC 39.82
- Support Level
- XPER $6.40
- BNTC $12.47
- Resistance Level
- XPER $6.70
- BNTC $13.95
- Average True Range (ATR)
- XPER 0.30
- BNTC 1.27
- MACD
- XPER -0.13
- BNTC -0.15
- Stochastic Oscillator
- XPER 0.00
- BNTC 32.36
About XPER Xperi Inc.
Xperi Inc is a consumer and entertainment technology company. Its offering comprises a portfolio of software and services. The company creates extraordinary experiences at home and on the go for millions of consumers around the world, enabling audiences to connect with content in a more intelligent, immersive, and personal way. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment. Its also have sales in Japan, Europe and Middle East, China, South Korea, Latin America, and Others.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.